News & Media, page-814

First 814 Last

Share
Profile

Follow
cameo

827 Posts.

139

22/10/18

19:42

Post #: 36215747
Share

Originally posted by StockLog ↑

Cameo,

Thank you for posting. Refreshing to see a post that actually has substance and not just the repetitive up-ramp or down-ramp.
Today's announcement certainly a positive one progress SAS to the next step. Not sure though how you worked out the 14 weeks part.....
I do not have the reference but if memory serves me right I am fairly sure that Meir sated that we will go up with VG on the third or forth trip.
This would give GOMSpace plenty of time to manufacture the first 20 Pearls that we need initially.
I do also recall that SAS mentioned that they will have a back up plan and down time will be minimal shell anything not go according to plan. This means that the next 20 (or 25) should be ready to go by the time the first batch is deployed. Not quite sure how they will achieve that as the funding still orbits around everyone's minds to how this will take place.
The advantage of not going with the first 'Cosmic Girl' deployment is that by the third deployment the VO team will have enough time to iron out any glitches. It defiantly de-risks the deployment from SAS perspective and should give SH more confidence.
Time is sure ticking much faster now as we get closer and closer.

DYOR & GLTA

Expand

Hi Stocklog... todays announcement said Gomspace to start immediately on production
They currently punch out 1 nano a week so ,we got 20 sats to make would take us to end of February....of course can't expect them to be immediately deployed into space straight away....
If Gomspace can ramp up abit too shorten the production time line they may get them up earlier....

SAS Price at posting: 5.9¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

There are more pages in this discussion • 2,416 more messages in this thread...

First 814 Last

Add SAS (ASX) to my watchlist

News & Media, page-814

Top Stories

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Featured News